Can a fitness tracker help measure activity in cancer trials?
Part of Cancer clinical trials.
This study tests whether wearing a fitness tracker (like a step counter) is a practical way to measure how active you are while you are in an early-phase cancer clinical trial. It will help researchers see if this is something they can use in future trials.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must agree to take part in the study.
- You are at least 16 years old.
- You have already agreed to join an early-phase cancer clinical trial.
- You are willing to wear a small device (like a fitness tracker) for the whole study.
- You are willing to follow the study's schedule and procedures.
- Your daily activity level is fully up or only slightly limited (ECOG score 0 or 1).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether patients in early-phase cancer trials can comfortably use smartwatches and phone apps to track their health and report how they're feeling. The goal is to see if these tools can help doctors better understand how cancer treatments affect daily life.
This trial tests whether using a Fitbit smartwatch to track your vital signs (like heart rate) can help catch problems early in people with stomach or esophageal cancer starting chemotherapy. You'll wear the watch and your care team will monitor the data to see if it improves safety and outcomes.
This trial tests if a wearable device paired with a smartphone app can help monitor symptoms in cancer survivors. The goal is to improve how we track and manage symptoms during and after treatment.
This trial tests if a program can help people who are not very active start and stick with a physical activity routine. Participants will wear a study-provided smartwatch to track their activity and answer brief surveys.
This study tests whether using a wearable activity tracker can help reduce hospitalizations in people undergoing radiation therapy for cancer. Participants will wear a tracker to monitor their activity levels during treatment.
This study compares how physical activity answers on a questionnaire match what a motion tracker measures. It may help researchers understand activity levels in people with lymphoma, colorectal, or pancreatic cancer during treatment.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.